CERO Cero Therapeutics Holdings, Inc.

Fundamentals / CIK 0001870404 / USD
Other share classes on CIK 0001870404: CEROW

Cero Therapeutics Holdings, Inc. reported $1.83M in total assets and a net loss of $7.44M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CERO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$18.63MFY 2022 Net Income: -$668K2022FY 2023 Net Income: -$7.29M2023FY 2025 Net Income: -$19.92M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development -- $5.29M --
Total Operating Expenses -- $7.68M $2.91M
Operating Income -- -$7.68M -$2.91M
Interest Income -- $492K $2.84M
Interest Expense -- -$138K --
Income Before Tax -$19.92M -$2.44M -$69K
Income Tax Expense -- $95K $599K
Net Income -$19.92M -$7.29M -$668K
Basic EPS -- -$4,994,560,000.00 --
Diluted EPS -- -$4,994,560,000.00 --
Basic Shares Outstanding -- 0 --
Diluted Shares Outstanding -- 0 --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Research & Development $1.97M $1.74M $2.34M -- $2.39M $2.75M $2.91M $1.77M
Total Operating Expenses $3.19M $3.85M $4.85M -- $4.36M $4.72M $4.95M $4.40M
Operating Income -$3.19M -$3.85M -$4.85M -- -$4.36M -$4.72M -$4.95M -$4.40M
EBITDA -$3.14M -$3.79M -- -- -$4.29M -$4.65M -$4.87M -$4.29M
Interest Income $1.1K $1.0K $3.1K -- $5.9K $14K $850 --
Interest Expense $918K $690K $166K -- -- -- -- --
Net Income $4.02M -$1.03M -$5.89M -$4.54M -$4.86M -$5.42M -$5.11M -$4.23M
Basic EPS $0.06 -$0.70 -$0.20 -- -$9.10 -$61.71 -$31.82 -$170.22
Diluted EPS $0.00 -$0.70 -$0.20 -- -$9.10 -$61.71 -$31.82 -$170.22
Basic Shares Outstanding 72.8M 42.2M 28.8M -- 1.3M 488.1K 171.4K 24.8K
Diluted Shares Outstanding 1.09B 42.2M 28.8M -- 1.3M 488.1K 171.4K 24.8K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.70M $1.88M $97K $476K $1.10M
Cash & Short-Term Investments $1.70M $1.88M $97K $476K $1.10M
Total Current Assets $2.73M $3.71M $1.97M $42.37M $1.36M
Property, Plant & Equipment, Net $246K $529K $967K -- --
Total Non-Current Assets $907K $2.49M $3.16M $0 $178.7M
Total Assets $3.64M $6.21M $5.13M $42.37M $180.1M
Accounts Payable $7.58M $4.51M $1.67M -- $14K
Other Current Liabilities $692 $692 -- -- --
Total Current Liabilities $9.09M $7.40M $3.51M $30.75M $98K
Deferred Revenue (Non-Current) -- -- $9.15M $9.15M --
Total Non-Current Liabilities $0 $699K $1.58M $9.15M $9.15M
Total Liabilities $9.09M $8.10M $5.08M $39.90M $9.25M
Total Debt (incl. Leases) $1.04M $1.58M $2.34M -- --
Common Stock -- -- $1 $88 --
Retained Earnings -$90.84M -$70.92M -$43.09M -$11.00M --
Total Stockholders' Equity -$5.45M -$1.89M -$42.06M -$11.00M -$7.67M
Total Equity -$5.45M -$1.89M -$42.06M -$11.00M -$7.67M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $456K $863K $857.5B $1.70M $1.95M $3.23M $5.10M $1.88M
Cash & Short-Term Investments $456K $863K $857.5B $1.70M $1.95M $3.23M $5.10M $1.88M
Total Current Assets $975K $1.55M $1.57M $2.73M $2.55M $4.25M $5.77M $3.71M
Property, Plant & Equipment, Net $71K $126K $184K $246K $313K $383K $452K $529K
Total Non-Current Assets $854K $352K $631K $907K $1.36M $1.96M $2.22M $2.49M
Total Assets $1.83M $1.90M $2.21M $3.64M $3.91M $6.20M $7.99M $6.21M
Accounts Payable $7.61M $8.22M $7.69M $7.58M $7.08M $6.21M $6.38M $4.51M
Other Current Liabilities $692 $692 $692 $692 -- -- -- $692
Total Current Liabilities $20.32M $32.41M $11.33M $9.09M $8.45M $7.62M $7.86M $7.40M
Long-Term Debt -- -- $137K -- -- -- -- --
Total Non-Current Liabilities $354K $0 $137K $0 $0 $218K $462K $699K
Total Liabilities $20.67M $32.41M $11.46M $9.09M $8.45M $7.84M $8.32M $8.10M
Total Debt (incl. Leases) $669K $233K $794K $1.04M $931K $1.15M $1.37M $1.58M
Retained Earnings -$93.73M -$97.75M -$96.72M -$90.84M -$86.30M -$81.44M -$76.02M -$70.92M
Total Stockholders' Equity -$18.84M -$30.51M -$9.26M -$5.45M -$4.54M -$1.63M -$329K -$1.89M
Total Equity -$18.84M -$30.51M -$9.26M -$5.45M -$4.54M -$1.63M -$329K -$1.89M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income $19.90M -$7.29M -$668K
Stock-Based Compensation $1.10M $97K --
Operating Cash Flow -$16.10M -$1.52M -$1.09M
Purchases of Investments -- -$178.5M --
Investing Cash Flow -- -$7.94M $180.8M
Common Stock Issued -- -- $0
Share Repurchases -- -$33.48M -$139.4M
Dividends Paid -$127K -- --
Financing Cash Flow -- -$32.58M -$138.7M
Net Change in Cash -- -$42.04M $41.04M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Net Income -$4.00M $1.00M $5.90M -$4.54M -$4.86M -$5.42M -$5.11M -$4.23M
Depreciation & Amortization $55K $59K -- -- $69K $76K $76K $114K
Stock-Based Compensation $122K $1.12M $1.62M $260K $348K $183K $305K --
Operating Cash Flow -$3.03M -$7.89M $2.80M -- -- -- -- --
Dividends Paid -- -- -$127K $0 $0 $0 -$127K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -547.1% -142.2% -1.6%
Current Ratio 0.30x 0.56x 1.38x
Quick Ratio 0.19x 0.03x 0.02x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Return on Assets (ROA) -406.7% -858.5% -938.7% -547.1% -- -- -- --
Current Ratio 0.05x 0.05x 0.14x 0.30x 0.30x 0.56x 0.73x --
Quick Ratio 0.02x 0.03x 75702.43x 0.19x 0.23x 0.42x 0.65x --
Source: SEC EDGAR CompanyFacts (CIK 0001870404) · from September 30, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal